date:Nov 23, 2012
This will be followed by a further ten year 'black out' period in which Nestl would not be permitted to re-enter the markets with Pfizer's brands.
The undertaking has been designed to avoid competition concerns and create an effective, independent and long-term competitor.
Meanwhile, Mexico's antitrust agency has rejected Nestl's acquisition of Pfizer's infant nutrition business stating that it would give the company a large share in the local market for infant formula, allowing it to increas